Laurent Pharmaceuticals annonces publication of results from Phase 2 study of LAU-7b for the treatment of CF in the Journal of Cystic Fibrosis
Laurent Pharmaceuticals, Inc., a Montreal-based biopharmaceutical company, today announced the publication in the peer-reviewed Journal of Cystic Fibrosis of previously disclosed results from its Phase 2 study of LAU-7b for the treatment…
